1. Home
  2. FBGL vs MBRX Comparison

FBGL vs MBRX Comparison

Compare FBGL & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FBGL

FBS Global Limited Ordinary Shares

HOLD

Current Price

$0.62

Market Cap

11.3M

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$2.58

Market Cap

12.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBGL
MBRX
Founded
1996
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
12.8M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
FBGL
MBRX
Price
$0.62
$2.58
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$61.00
AVG Volume (30 Days)
148.1K
84.3K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.25
52 Week High
$1.40
$7.98

Technical Indicators

Market Signals
Indicator
FBGL
MBRX
Relative Strength Index (RSI) 47.39 52.94
Support Level $0.58 $0.39
Resistance Level $0.67 $2.77
Average True Range (ATR) 0.05 0.16
MACD 0.01 0.03
Stochastic Oscillator 43.59 52.08

Price Performance

Historical Comparison
FBGL
MBRX

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: